MultiPlan (NYSE:MPLN) Shares Down 4.4%

MultiPlan Co. (NYSE:MPLN - Get Free Report)'s share price fell 4.4% on Tuesday . The stock traded as low as $0.81 and last traded at $0.81. 147,080 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 1,499,187 shares. The stock had previously closed at $0.85.

MultiPlan Trading Down 2.4 %

The stock has a market cap of $534.31 million, a P/E ratio of -5.53 and a beta of 0.60. The firm's fifty day moving average price is $0.97 and its two-hundred day moving average price is $1.28. The company has a debt-to-equity ratio of 2.65, a current ratio of 1.16 and a quick ratio of 1.16.

MultiPlan (NYSE:MPLN - Get Free Report) last released its quarterly earnings results on Thursday, February 29th. The company reported ($0.06) earnings per share for the quarter. The firm had revenue of $244.14 million during the quarter. MultiPlan had a negative return on equity of 8.31% and a negative net margin of 9.54%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in MPLN. Sei Investments Co. bought a new position in MultiPlan in the third quarter valued at $26,000. SG Americas Securities LLC purchased a new stake in MultiPlan during the third quarter valued at about $27,000. Neo Ivy Capital Management purchased a new stake in MultiPlan during the second quarter valued at about $28,000. Ethic Inc. purchased a new stake in MultiPlan during the first quarter valued at about $28,000. Finally, Tower Research Capital LLC TRC boosted its position in MultiPlan by 159.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 20,883 shares of the company's stock valued at $30,000 after buying an additional 12,837 shares during the period. Institutional investors own 87.15% of the company's stock.

MultiPlan Company Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.